Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P325: Efficacy, safety, and long-term outcome of endoscopic dilation therapy for stricturing Crohn’s disease of the upper gastrointestinal tract: a combined analysis of 127 endoscopic balloon dilation proceduresECCO '16 Amsterdam
Year: 2016
Authors:

D. Bettenworth*1, M. M. Mücke1, A. Singh2, R. Lopez3, F. Rieder4, 5

1University Hospital Münster, Department of Medicine B, Münster, Germany, 2Cleveland Clinic Foundation, Department of Hospital Medicine, Cleveland, Ohio, United States, 3Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Cleveland, Ohio, United States, 4Cleveland Clinic Foundation, Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease Institute, Cleveland, Ohio, United States, 5Cleveland Clinic Foundation, Department of Pathobiology, Cleveland, Ohio, United States

P326: Validation of CUCQ-8 Questionnaire for Quality of Life Assessment in IBD PatientsECCO '16 Amsterdam
Year: 2016
Authors:

C. McGinley*1, C. Mowat2, M. Groome2, J. Todd2, N. Reynolds2

1University of Dundee, Dundee, United Kingdom, 2Ninewells Hospital and Medical School, Department of Gastroenterology, Dundee, United Kingdom

P327: Biosimilar infliximab in real-life Crohn’s disease’s anti-TNFalfa naïve patients: a comparative observational cohort study (SIMRECRO study)ECCO '16 Amsterdam
Year: 2016
Authors:

L. Carvalho Lourenço*, V. Anapaz, A. M. Oliveira, J. Branco, M. Cardoso, C. Graça Rodrigues, L. Santos, D. Horta, A. Martins, J. Reis

Hospital Prof Dr Fernando Fonseca, Serviço de Gastrenterologia, Amadora, Portugal

P328: Factors related to short- and long-term treatment results and usefulness of infliximab for refractory ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

Y. Takada*, S. Yasukawa, R. Amano, M. Yasaka, N. Takatsu, Y. Yano, F. Hirai

Fukukuoka University Chikushi hospital, Chikushino-shi, Japan

P329: Infliximab biosimilar in the treatment of inflammatory bowel disease: a Japanese single-cohort observational studyECCO '16 Amsterdam
Year: 2016
Authors:

S. Hamanaka*, T. Nakagawa, H. Koseki, T. Sakurai, T. Taida, K. Okimoto, K. Saito, D. Maruoka, T. Matsumura, T. Katsuno, M. Arai, O. Yokosuka

Graduate School of Medicine, Chiba University, Department of Gastroenterology and Nephrology, Chiba City, Japan

P330: Vitamin D insufficiency in patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

M. d. C. Martos Plasencia*, C. Verdejo Gil, R. H. Lorente Poyatos, E. De la Santa Belda, M. Peña Gómez, R. Salmoral Luque, B. López Viedma, J. Olmedo Camacho

University Hospital of Ciudad Real, Gastroenterology and Hepatology Department, Ciudad Real, Spain

P331: Allopurinol and azathioprine co-therapy or thioguanine dose splitting: shifting the shunters in the mercaptopurine pathway in a paediatric inflammatory bowel disease population—a single-centre experienceECCO '16 Amsterdam
Year: 2016
Authors:

S. Chadokufa*1, A. Lozinsky Rolnik2, S. Sider1, N. Acton3, B. Huggett3, N. Shah4, F. Kiparissi1

1Great Ormond Street Hospital, Gastro, London, United Kingdom, 2Great Ormond Street Hospital, Gastro, LONDON, United Kingdom, 3Great Ormond Street, London, United Kingdom, 4Great Ormond Street, Gastro, London, United Kingdom

P332: Influence of mesalamine maintenance therapy on progression of ulcerative proctitis in KoreaECCO '16 Amsterdam
Year: 2016
Authors:

Y. S. Choi1, W. J. Kim*2, H.-J. Jung3, J. K. Kim1, K.-H. Song3

1Daehang Hospital, Gastroenterology, Seoul, South Korea, 2Soonchunhyang University Hospital, Gastroenterology, Gumi-si, South Korea, 3Daehang Hospital, Surgery, Seoul, South Korea

P333: Long-term efficacy and safety of thiopurines in patients with steroid-dependent ulcerative colitis: a retrospective investigationECCO '16 Amsterdam
Year: 2016
Authors:

Y. Yokoyama*, T. Sato, M. Kawai, Y. Kita, K. Kamikozuru, T. Miyazaki, M. Iimuro, N. Hida, S. Nakamura

Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine, Nishinomiya, Japan

P334: Evolution of a long-term follow-up cohort of Crohn’s disease with complex perianal fistula: from antibiotic to combined AZA and anti-TNF based treatment ending up clinical and radiological healing with or without stomaECCO '16 Amsterdam
Year: 2016
Authors:

Y. Erzin*, K. Ercaliskan, I. Hatemi, K. Atay, S. Bozcan, N. Demir, A. F. Celik

Istanbul University Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey

P335: Cancer recurrence with immunosuppressive therapy in immune-mediated diseases: a systematic review and meta-analysisECCO '16 Amsterdam
Year: 2016
Authors:

E. Shelton*1, D. Laharie2, F. Scott3, R. Mamtani4, J. Lewis4, J.-F. Colombel5, A. Ananthakrishnan1

1Massachusetts General Hospital, Boston, Massachusetts, United States, 2University-Bordeaux, Bordeaux, France, 3University of Pennsylvania, Philadelphia, Pennsylvania, United States, 4University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Philadelphia, Pennsylvania, United States, 5Mount Sinai, Icahn School of Medicine, New York, New York, United States

P336: French prospective, longitudinal observational study of the therapeutic management of mild to moderate ulcerative colitis (Optimum study): follow-up at 3 yearsECCO '16 Amsterdam
Year: 2016
Authors:

S. Nahon*1, G. Bonnaud2, F. Bahbah3

1Centre Hospitalier Le Raincy, Montfermeil, France, 2Ambroise Paré Private hospital, IBD Unit, Toulouse, France, 3Ferring Pharmaceuticals, Gentilly, France

P337: Anti-TNFalpha therapy is associated with rapid reduction of circulating monocyte numbers and blunted monocyte pro-inflammatory response in patients with Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

S. Slevin*1, C. Dennedy2, A. Ribeiro1, R. Ceredig1, M. Griffin1, L. Egan2

1National University of Ireland Galway, REMEDI, Galway, Ireland, 2National University of Ireland Galway, Pharmacology and Therapeutics, Galway, Ireland

P338: Rate and predictors of mucosal healing in patients with ulcerative colitis treated with thiopurines: results of a multicentric cohort studyECCO '16 Amsterdam
Year: 2016
Authors:

C. Prieux-Klotz*1, S. Nahon2, A. Amiot3, L. Sinayoko4, C. Galéano-Cassaz5, S. Chaussade1, P. Lahmek6, V. Abitbol1

1C.H.U. Cochin, Paris, France, 2C.H. Le Raincy Montfermeil, Montfermeil, France, 3C.H.U. Henri Mondor, Créteil, France, 4H.I.A. Bégin, Saint Mandé, France, 5H.I.A. Val de Grâce, Paris, France, 6C.H. Emile Roux, Limeil-Brévannes, France

P339: The efficacy of intravenous iron therapy in IBD patients with active disease is not influenced by the degree of inflammatory activityECCO '16 Amsterdam
Year: 2016
Authors:

A. Walper*1, A. Dignass2, 3, J. Stein3, 4

1Medice Arzneimittel GmbH, Iserlohn, Germany, 2Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany, 3Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 4DGD Clinics Sachsenhausen, Frankfurt/Main, Germany

P340: Postoperative clinical recurrence in Crohn’s disease patients: the Practicrohn studyECCO '16 Amsterdam
Year: 2016
Authors:

E. Domènech*1, V. García2, M. D. Martín Arranz3, M. Barreiro-de Acosta4, A. Gutiérrez5, L. Cea-Calvo6, C. Romero6, B. Juliá6

1Hospital Universitari Germans Trias i Pujol and CIBERehd, Gastroenterology Unit, Badalona, Spain, 2Hospital Universitario Reina Sofia, Unidad Clinica de Aparato Digestivo, Cordoba, Spain, 3Hospital Universitario La Paz, Gastroenterology Unit, Madrid, Spain, 4Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 5Hospital General Universitario Alicante, Gastroenterology Unit, Alicante, Spain, 6MSD Spain, Medical Department, Madrid, Spain

P341: Analytical performance of a new iPhone-based patient monitoring system comparable to ELISA for measuring faecal calprotectin in inflammatory bowel disease patientsECCO '16 Amsterdam
Year: 2016
Authors:

K. F. Wintgens*1, A. A. Wulandari2, A. Dignass3, 4, F. Hartmann3, 4, J. Stein2, 3

1Immundiagnostik AG, Bensheim, Germany, 2DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 3Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 4Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany

P342: Tryptophan as a biomarker for the course of IBD and anti-TNF α responseECCO '16 Amsterdam
Year: 2016
Authors:

B. Brandt*1, S. Nikolaus2, N. Al-Massad2, J. Bethge2, D. Schuldt2, S. Szymczak3, F. Thieme4, G. H. Waetzig5, M. Krawczak3, R. Junker4, P. Rosenstiel6, S. Schreiber2

1UKSH Kiel, Department of Internal Medicine I, Kiel, Germany, 2UKSH, Department of Internal Medicine I, Kiel, Germany, 3UKSH, Institute of Medical Informatics and Statistics, Kiel, Germany, 4UKSH, Institute of Clinical Chemistry, Kiel, Germany, 5Conaris Research Institute AG, Kiel, Germany, 6UKSH, Institute of Clinical Molecular Biology, Kiel, Germany

P343: The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease and the relationship with biochemical markers of disease activityECCO '16 Amsterdam
Year: 2016
Authors:

K. Diederen1, D. Hoekman*1, T. Hummel2, T. de Meij3, B. Koot1, M. Tabbers1, A. Vlieger4, A. Kindermann1, M. Benninga1

1Academic Medical Centre (AMC), Department of Paediatric Gastroenterology, Amsterdam, Netherlands, 2Medisch Spectrum Twente, Department of Paediatrics, Enschede, Netherlands, 3VU University Medical Centre, Department of Paediatric Gastroenterology, Amsterdam, Netherlands, 4St. Antonius Hospital, Department of Paediatrics, Nieuwegein, Netherlands

P344: Non-adherence to medical therapy is associated with hospitalisations and the development of active disease in inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

M. Severs*1, H. H. Fidder1, M.-J. Mangen2, M. E. van der Valk1, M. van der Have1, A. A. van Bodegraven3, 4, C. H. M. Clemens5, G. Dijkstra6, J. M. Jansen7, D. J. de Jong8, N. Mahmmod9, P. C. van de Meeberg10, A. E. van der Meulen- de Jong11, M. Pierik12, C. Y. Ponsioen13, M. J. L. Romberg- Camps3, P. D. Siersema1, J. R. Vermeijden14, J. van der Woude15, P. N. Zuithoff16, B. Oldenburg1

1University Medical Centre Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands, 2University Medical Centre Utrecht, Julius Centre for Health Sciences and Primary Care, Utrecht, Netherlands, 3ORBIS medical Centre, Gastroenterology and Hepatology, Sittard, Netherlands, 4VU medical Centre, Gastroenterology and Hepatology, Amsterdam, Netherlands, 5Diaconessenhuis, Gastroenterology and Hepatology, Leiden, Netherlands, 6University Medical Centre Groningen, Gastroenterology and Hepatology, Groningen, Netherlands, 7Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, Netherlands, 8University Medical Centre St. Radboud, Gastroenterology and Hepatology, Nijmegen, Netherlands, 9Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands, 10Slingeland Hospital, Gastroenterology and Hepatology, Doetinchem, Netherlands, 11Leiden University Medical Centre, Gastroenterology and Hepatology, Leiden, Netherlands, 12University Medical Centre Maastricht, Gastroenterology and Hepatology, Maastricht, Netherlands, 13Academic Medical Centre Amsterdam, Gastroenterology and Hepatology, Amsterdam, Netherlands, 14Meander Medical Centre, Gastroenterology and Hepatology, Amersfoort, Netherlands, 15Erasmus Medical Centre, Gastroenterology and Hepatology, Rotterdam, Netherlands, 16University Medical Centre Utrecht, Julius Centre for Health Sciences and Primary Care, Utrecht, Netherlands